Is Celgene (CELG) Poised for a Beat This Earnings Season?





Is Celgene (CELG) Poised for a Beat This Earnings Season?Celgene Corporation (CELG) is expected to beat estimates once again on the back of strong performance of key drug Revlimid.


READ MORE